Content Details
Information on this page was last modified on : 2024/06/01 2:59:07 PM

Lartruvo (olaratumab) injection, 500 mg/50 ml

Belongs to Category

Lartruvo, with the active ingredient olaratumab, is a monoclonal antibody designed to interfere with the growth and spread of cancer cells. It is used specifically for the treatment of soft tissue sarcoma (STS) and is administered via injection. The concentration of Lartruvo is 500 mg/50 mL (10 mg/mL).

How It Works

Lartruvo targets a protein called platelet-derived growth factor receptor alpha (PDGFR-α), which is found on the surface of some cancer cells. By binding to PDGFR-α, Lartruvo blocks its interaction with platelet-derived growth factor (PDGF), preventing the receptor from sending growth signals to the cancer cells. This inhibition can slow down or stop the proliferation of cancer cells and potentially shrink tumors. Lartruvo is often used in combination with doxorubicin, a chemotherapy drug, to enhance its effectiveness in treating soft tissue sarcoma.

Side Effects

  • Nausea
  • Fatigue
  • Musculoskeletal pain
  • Mucositis
  • Diarrhea
  • Vomiting
  • Hair loss
  • Neutropenia (low levels of neutrophils)
  • Infusion-related reactions
  • Decreased appetite


  • Lartruvo is indicated for the treatment of adult patients with soft tissue sarcoma (STS) who have not been previously treated with chemotherapy and whose disease is not amenable to curative treatment with radiotherapy or surgery.


  • Severe allergic reactions to olaratumab or any of its components
  • Pregnancy, as it may harm the fetus
  • Breastfeeding, due to potential risk to the infant
  • Severe liver impairment
  • Severe renal impairment

Price in Different Countries

Country Price (USD) Reference
United States $1,200
United Kingdom £950 NHS UK
Canada CAD 1,500 Canada Drugs
Australia AUD 1,700 PBS Australia
Germany €1,100 Gelbe Liste

Top 5 Global Brands

  • Pfizer
  • Roche
  • Johnson & Johnson
  • Merck & Co.
  • Novartis
Additional Information:

One of the following licensed pharmacy from the nearest location will deliver Lartruvo (olaratumab) injection, 500 mg/50 ml. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions


There are no reviews yet.

Be the first to review “Lartruvo (olaratumab) injection, 500 mg/50 ml”
Shopping Cart